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ttp://dx.doi.org/10.1016/j.ajpath.2013.05.001Although it is clear that T helper (Th)17 cells play a pathologic role in the pathogenesis of several
inﬂammatory diseases, the contribution and regulation of pathogenic Th17 cells in the development
of glomerulonephritis are still not fully understood. Herein, we show that IL-10edeﬁcient mice
exhibit exacerbation of glomerulonephritis after induction with antieglomerular basement membrane
globulin, with enhanced pathogenic Th17 immune responses. We further demonstrate that Rag1/
mice reconstituted with IL-10/ CD4þ T cells develop more severe glomerulonephritis after
induction of antieglomerular basement membrane disease, with more inﬁltration of inﬂammatory
cells into the kidneys. Finally, IL-17 and interferon g double-positive cells were signiﬁcantly
increased in IL-10/ CD4þ T-cell cultures under pathogenic Th17 conditions compared with wild-
type cell cultures. These ﬁndings suggest that T-cellederived IL-10 plays a critical suppressive
role in the control of pathogenic Th17 cell differentiation and highlights the importance of IL-10 as
protection against glomerulonephritis development. (Am J Pathol 2013, 183: 402e412; http://
dx.doi.org/10.1016/j.ajpath.2013.05.001)Supported by NIH grants P01 DK072201 and R56AI091871 and by the
Broad Medical Research Program of The Broad Foundation (H.X.).
R.Z. and Q.L. contributed equally to this work.T helper (Th)17 cells, which are clearly distinct from Th1 and
Th2 cells, have been deﬁned as an additional Th cell subset
that mediates proinﬂammatory and autoimmune responses
through the production of Th17 signature cytokines,
including IL-17A, IL-17F, and IL-22.1e4 Synergy between
the cytokines transforming growth factor (TGF)-b and IL-6
induces in vitro development of Th17 cells,5e8 whereas IL-
23 promotes the survival and expansion of Th17 cell pop-
ulations.2,5,9,10 IL-23 is also believed to play an important
role in the development of pathogenic Th17 cells.11 Several
transcription factors are involved in the regulation of Th17
cell differentiation. Among them, RORgt, a member of the
orphan nuclear receptor family, has been identiﬁed as the
master transcription factor for Th17 cell development.12
Other transcription factors, including RORa, STAT3,
IRF4, and IRF8, are also involved in the control of Th17 cell
differentiation.13 In addition, the differentiation of Th17 cells
is also regulated by several positive and negative feedback
loops involving IL-21, IL-23R, IL-10, and IL-27.6,7,14e18stigative Pathology.
.There is increasing evidence that Th17 cells are involved
in the pathogenesis of various autoimmune/inﬂammatory
diseases, including multiple sclerosis, rheumatoid arthritis,
inﬂammatory bowel diseases, and asthma.19 Thus, a more
complete understanding of the molecular mechanisms in-
volved in the regulation of Th17 immune responses and its
roles indifferent inﬂammatorydiseases shouldprovide insights
into the pathogenesis and treatment of inﬂammatory diseases.
Glomerulonephritis (GN) is a renal disease observed as
inﬂammation in glomeruli and small blood vessels of the
kidneys.20 The presentation of GN may include hematuria,
proteinuria, and a variable degree of renal failure.20 The
mechanisms underlying the pathogenesis of GN are incom-
pletely understood. It has been believed that Th1-mediated
immune responses are involved in the development of
IL-10 Controls Pathogenic Th17 CellsGN,21,22 but more recent studies suggest that Th17 cells
instead of Th1 cells contribute to the pathogenesis of
GN.23e26However, the functions and regulation of Th17 cells
in the development of GN still need to be further explored.
IL-10, identiﬁed by Mosmann and colleagues in 1989,27 is
a pluripotent cytokine produced by many activated immune
cell types, including Th cells, B cells, macrophages, mono-
cytes, and keratinocytes.28 IL-10 activates through the IL-10
receptor (IL-10R), which is expressed on a variety of cell
types.28 The IL-10R is composed of two chains, IL-10R1 and
IL-10R2.28 Interaction of IL-10 with the IL-10R results in
STAT3-mediated signal transduction.29 IL-10 inhibits Th1
cell differentiation and IL-12 production in macrophages.We
recently demonstrated that IL-10 plays a negative role in the
regulation of Th17 cell development.18 IL-10edeﬁcient mice
spontaneously develop colitis; a condition once attributed to
an enhanced Th1 immune response. Recent studies suggest
that Th17 cells may contribute to the development of colitis
in IL-10edeﬁcient mice.30 Kitching et al31 reported that
endogenous IL-10 regulates Th1 immune responses that
induce crescentic GN. However, the importance of IL-10 in
the regulation of pathogenic Th17 cell differentiation during
the development of GN is still not fully understood.
In the present study, we show that mice deﬁcient in IL-10
exhibit more severe GN after induction with antieglomerular
basement membrane (aGBM) globulin, with enhanced Th17
immune responses. We further demonstrate that Rag1/
mice reconstituted with IL-10/CD4þ T cells develop more
severe GN after induction of aGBM disease, with more
inﬁltration of inﬂammatory cells into the kidneys. Finally, the
IL-17 and interferon (IFN)-g double-positive cell pop-
ulations were signiﬁcantly higher in IL-10/ CD4þ T-cell
cultures under pathogenic Th17 conditions compared with
wild-type (WT) cell cultures, and the double-positive cells
were signiﬁcantly increased in IL-10/ mice with GN.
These ﬁndings suggest that IL-10 plays a critical suppressive
role in the control of pathogenic Th17 cell differentiation and
highlights the importance of IL-10 as protection against GN
development.
Materials and Methods
Mice
C57BL/6J and IL-10edeﬁcient mice were obtained from The
Jackson Laboratory (Bar Harbor, ME) and were maintained
in the barrier facility at the Icahn School of Medicine at
Mount Sinai (New York, NY). The animal study protocols
were approved by the Institutional Animal Care and Use
Committees of the Icahn School of Medicine at Mount Sinai.
Antibodies
The following antibodies were purchased from BDBiosciences
(San Diego, CA), as conjugated to ﬂuorescein isothiocyanate,
phosphatidylethanolamine, phosphatidylethanolamine-Cy5,The American Journal of Pathology - ajp.amjpathol.orgperCP-Cy5.5, or APC: CD4 (L3T4), CD8 (53-6.7), CD3e
(145-2C11), CD25 (PC61.5), CD44 (IM7), CD62L (MEL-
14), CD45RB (C363-16A), IL-17 (TC11-18H10), IFN-g
(XMG1.2), and isotype controls. Antibodies for IL-2 (JES6-
1A12), RORg (B2D), IL-10 (JES5-16E3), and Foxp3 (FJK-
16S)were purchased from eBioscience Inc. (SanDiego, CA).
Induction of Accelerated aGMB GN
WT and IL-10/ mice (n Z 8 per group) were sensitized
by s.c. injection of 0.5 mg of sheep globulin (SG) in Freund
complete adjuvant. Five days later, SG-sensitized mice were
injected i.p. with sheep anti-mouse GMB antibody at 30 mg
per mouse. Renal injury and systemic immune responses
were assessed 14 days later. For assessment of antigen-
speciﬁc immune responses, a separate group of mice was
injected s.c. with SG in Freund complete adjuvant, and the
mice were sacriﬁced 1 week later.
CD4þ T-Cell Preparation and Differentiation in Vitro
Naive CD4þ T cells (CD62LþCD44lo) were prepared by
ﬂuorescence-activated cell sorting (FACS) from the spleens
and lymph nodes of IL-10/ mice and their WT littermates.
The sorted cells were primed for 96 hours with 1 mg/mL of
anti-CD3 (145-2C11; BD Biosciences) and 2 mg/mL of
soluble anti-CD28 (37.51; BD Biosciences). The cells were
rested for 48 hours and were then restimulated for 5 hours
with phorbol 12-myristate 13-acetate (PMA) plus ion-
omycin in the presence of brefeldin A, and intracellular
cytokines were measured by ﬂow cytometry. Cells stimu-
lated under neutral conditions were deﬁned as Th0 cells.
Cells were stimulated to differentiate into Th1 cells by
supplementation with IL-12 plus antieIL-4 or into Th2 cells
by supplementation with IL-4 and antieIFN-g. For Th17
cell differentiation, cells were stimulated with 5 ng/mL of
TGF-b1, 20 ng/mL of IL-6 added with or without 10 ng/mL
of IL-23 (all from R&D Systems, Minneapolis, MN) in the
presence of 10 mg/mL of antieIL-4 antibody (11B11; BD
Bioscences).
Assessment of Renal Injuries
Glomerular abnormalities were analyzed on PAS-stained,
Bouin-ﬁxed, parafﬁn-embedded sections (3 mm thick) using
coded slides. Abnormalities included crescent formation and
severe necrosis. A minimum of 50 glomeruli were analyzed
per animal to determine the percentage of crescentic
glomeruli. Semiquantitative analysis of tubulointerstitial
damage was performed in each mouse as previously pub-
lished32,33 using 10 randomly selected cortical areas (200).
Injury was deﬁned as tubular dilation, tubular atrophy,
sloughing of tubular epithelial cells, or thickening of the
basement membrane.32,33 Each cortical ﬁeld was scored
(0 to 4) according to the amount of injury: 0 indicates no
interstitial damage; 1, 25% of the tubulointerstitium damaged;403
Figure 1 IL-10edeﬁcient mice develop more severe GN. WT and IL-10/
mice were sensitized with SG for 5 days, and themice were then were injected
i.p. with sheep anti-mouse GBM globulin at a dose of 30 mg per mouse. Renal
injuries were assessed 14 days later. A: PAS staining of glomeruli in WT and
IL-10/ mice. B: Quantiﬁcation of histologic injury showed aggravation of
GN in IL-10/ mice (n Z 6 per group). gcs, glomerular cross section. C:
Functional injury indicated more albuminuria and higher serum urea levels in
IL-10/ mice (nZ 6 per group). Data are given as means  SD. *P < 0.05
versus IL-10/ mice.
Zhang et al2, 25% to 50% damaged; 3, 50% to 75% damaged; and
4, >75% of the tubulointerstitium damaged. For urine
collection, mice were housed for 24 hours in metabolic
cages with free access to tap water, whereas serum was
collected after the mice were sacriﬁced. Albuminuria was
analyzed by enzyme-linked immunosorbent assay (ELISA)
according to the manufacturer’s instructions (eBioscience).
Renal Leukocyte Inﬁltration
Kidney sections were ﬁxed in periodate-lysine-paraformal-
dehyde for 4 hours, washed with 20% sucrose solution, and
then frozen. Tissue sections were cut, and immunoﬂuores-
cence staining was used to stain for T cells, macrophages, and
neutrophils. The antibodies of anti-mouse CD3 (145-2C11),
antieMAC-2, and antieGr-1(RB6-8C5) were used as
primary antibodies to detect T cells, macrophages, and
neutrophils, respectively (BD Biosciences). At least 25
consecutively viewed glomeruli were assessed per animal,
and the results were expressed as cells per glomerular cross
section.404Intracellular Staining and Flow Cytometry
Cells were stimulated with PMA and ionomycin for 5 hours
in the presence of brefeldin A before intracellular staining.
Cells were ﬁxed with intracellular ﬁxation buffer (BD
Biosciences), incubated with permeabilization buffer, and
stained with phosphatidylethanolamineeanti-mouse IL-17,
APCeantieIFN-g, and phosphatidylethanolamine-Cy5.5
anti-mouse CD4 antibodies. Flow cytometry was performed
using a FACSCalibur system (BD Biosciences).RNA Isolation and Real-Time RT-qPCR
Total RNA was extracted using an RNeasy Plus kit (Qiagen
Inc., Valencia, CA), and cDNA was generated using an oligo
(dT) primer and the SuperScript II system (Invitrogen,
Carlsbad, CA), followed by analysis using iCycler PCR with
SYBR Green PCR master mix (Applied Biosystems, Foster
City, CA). Results were normalized based on the expression
of ubiquitin. The following primer sets (sense and antisense)
were used: IL-17A, 50-CTCCAGAAGGCCCTCAGACT-
AC-30 and 50AGCTTTCCCTCCGCATTGACACAG-30; IL-
21, 50-CGCCTCCTGATTAGACTTCG-30 and 50-GCCCC-
TTTACATCTTGTGGA-30; RORgt, 50-CCGCTGAGAGG-
GCTTCAC-30 and 50-TGCAGGAGTAGGCCACATTAC-
A-30; and ubiquitin, 50-TGGCTATTAATTATTCGGTCT-
GCA-30 and 50-GCAAGTGGCTAGAGTGCAGAGTAA-30.Cell Transfer Studies
Splenocytes or CD4þ T cells from WT and IL-10/ mice
were injected i.p. into Rag1/ recipients (1  107 spleno-
cytes or 4 106 CD4þ T cells per mouse in 200 mL of sterile
PBS per injection). Mice were then immunized by s.c.
injection of 0.5 mg in Freund complete adjuvant, and 5 days
later the SG-sensitized mice were i.p. injected with sheep
anti-mouse GBM globulin at a dose of 30 mg per mouse.
Fourteen days later, renal injury and systemic immune
responses were assessed. For evaluation of antigen-speciﬁc
immune responses, a separate group of mice was weighed
every week throughout the course of the experiments. After
5 weeks, the mice were sacriﬁced and their kidney tissues
were excised. The tissues were ﬁxed in 10% buffered
formalin and were parafﬁn embedded. Tissue sections (5 mm
thick) were stained with H&E. All the slides were read and
scored by an experienced pathologist without previous
knowledge of the type of treatment. The degree of inﬂam-
mation in the epithelium, submucosa, and submuscularis
propria was scored separately as described previously.34Cytokine ELISA
Supernatants from cell cultures were collected after activa-
tion under various conditions, and secreted cytokines in the
supernatants were measured by ELISA kits with puriﬁedajp.amjpathol.org - The American Journal of Pathology
IL-10 Controls Pathogenic Th17 Cellscoating and biotinylated detection antibodies: antieIL-17
(R&D Systems).
Statistical Analysis
Statistical analysis was performed using Student’s t-test.
P < 0.05 was considered statistically signiﬁcant.The American Journal of Pathology - ajp.amjpathol.orgResults
IL-10 Deﬁciency Exacerbates GN
To investigate the function of IL-10 in the development of
GN, we induced GN by using the aGBM disease model.
IL-10edeﬁcient mice developed more severe nephritis after
injection of aGBM globulin into sensitized mice compared
with WT mice (Figure 1A). IL-10/ mice displayed more
severe histologic and functional renal injury and exhibited
more glomerular crescents and severe interstitial injury
(Figure 1B). In addition, IL-10/ mice also had more albu-
minuria and higher serum urea nitrogen levels compared with
WTmice (Figure 1C). Taken together, the results suggest that
anti-inﬂammatory cytokine IL-10 plays a protective role in
the development of GN.
Enhanced Immune Responses in IL-10/ Mice with
aGBM Disease
Th17 cells are thought to be pathogenic in several inﬂam-
matory diseases. As such, a study of Th17 cell development
seems critical to understanding disease progression. We
began to investigate the development of Th17 cells in WT
and IL-10/ mice with GN. We prepared splenocytes from
WT and IL-10/ mice with GN induced by aGBM and
restimulated the cells with SG for 24 hours. After stimula-
tion, IL-17eproducing CD4þ T cells were analyzed by
FACS, and IL-17 protein production was determined by
ELISA. The percentage of IL-17eproducing CD4þ T cells
was signiﬁcantly higher in IL-10/ cell cultures (19.8%)
than in WT cell cultures (10.3%) (Figure 2A). Similarly, IL-
17 protein production was signiﬁcantly enhanced in IL-10/
cell cultures compared with WT cell cultures (Figure 2A).
Furthermore, we assessed inﬁltration of inﬂammatory cells in
the kidneys of WT and IL-10/ mice with GN. Histologic
analysis showed that IL-10/ mice have increased numbers
of glomerular CD3þ T cells, MAC-2þ macrophages, and
Gr-1þ neutrophils compared with WT mice (Figure 2, BeE),
suggesting that more inﬂammatory cells were present in the
kidneys of IL-10/ mice with GN. In addition, we also
analyzed Th1, regulatory T (Treg), and Th2 cells in WT and
IL-10/ mice with GN. Splenocytes from WT and IL-10/
mice with GN were restimulated with SG for 24 hours. IFN-
geproducing, IL-4eproducing, and Treg cells were analyzed
by FACS. The percentage of IFN-geproducing CD4þFigure 2 Enhanced immune responses in IL-10/ mice with GN. A:
Splenocytes were prepared from WT or IL-10/ mice with GN induced by
aGBM, and the cells were activated with SG for 24 hours. IL-17eproducing
CD4þ T cells were analyzed by FACS, and IL-17 protein levels in the super-
natants were determined by ELISA. *P < 0.05, versus immunized IL-10/
mice. B: WT or IL-10/mice were sensitized with SG for 5 days, and the mice
were then injected i.p. with sheep anti-mouse GBM antibody at a dose of 30
mg per mouse. Renal injuries were assessed 14 days later. The inﬁltration of
immune cells was analyzed by immunostaining in the kidneys. Quantiﬁcation
of T cells (C), macrophages (D), and neutrophils (E) in the kidneys of WT and
IL-10/ mice. gcs, glomerular cross section. Data are given as means SD.
405
Figure 3 Th17 and Th1 immune responses are enhanced in IL-10/ mice with GN. A: Cells from spleens and mesenteric lymph nodes were prepared from
WT and IL-10/ mice with GN induced by aGBM, and the cells were activated with SG for 24 hours. IFN-geproducing, IL-4eproducing, and Treg CD4þ T cells
were analyzed by FACS. B: Serum was collected from WT and IL-10/ mice with GN induced by aGBM, and the serum IgG level was determined by ELISA. C:
Total RNA was extracted from the kidneys of WT and IL-10/ mice with GN induced by aGBM, and real-time PCR was performed for the analysis of mRNA
expression of the indicated genes. *P < 0.05 versus immunized IL-10/ mice. Data are given as means  SD. Ubi, ubiquitin.
Zhang et alT cells was signiﬁcantly increased in IL-10/ cell cultures
(14.8%) compared with WT cell cultures (7.4%)
(Figure 3A). The percentages of IL-4eproducing and Treg
cells were comparable in WT and IL-10/ cell cultures
(Figure 3A). Furthermore, IgG levels in WT and IL-10/
mice with GN were similar, ruling out B-cell involvement as
a cause of IL-10/mice developing worse GN (Figure 3B).
Real-time PCR analysis indicated that the mRNA expression
of signature molecules for Th17 and Th1 cells was signiﬁ-
cantly enhanced in the kidneys of IL-10/ compared with
WT mice with GN (Figure 3C). Transcript levels of tran-
scription factors (Gata3 and FOXP3) for Th2 and Treg cells,
however, were not altered (Figure 3C). In addition, IL-10
mRNA expression was slightly increased in WT mice with
GN (Figure 4A). To investigate IL-10 expression from
different effector T cells, we activated naive CD4þ T cells
from C57Bl/6 mice under Th1, Th2, Th17, or Treg cell
conditions and found that all these effector T cells express406IL-10 (Figure 4B). Taken together, these results suggest that
IL-10 negatively regulates Th17 and Th1 immune responses
in the development of GN.
Transfer of CD4þ T Cells Induces More Severe GN in
RAG1/ Mice
These data suggest that Th17 cells may be involved in the
development of GN in IL-10/ mice. Next we wanted to
conﬁrm that the disease development is really due to CD4þ
T cells. We ﬁrst prepared splenocytes from WT and IL-10/
mice and transferred the cells into Rag1/ mice. Rag1/
mice reconstituted with IL-10/ splenocytes developed
more severe GN, with more severe histologic injury and
functional impairment of the kidney compared with mice
reconstituted with WT splenocytes after induction of aGBM
disease (Figure 5, A and B). In addition, mice reconstituted
with IL-10/ exhibited signiﬁcantly larger spleensajp.amjpathol.org - The American Journal of Pathology
Figure 4 IL-10 is expressed in different effector T cells. A: WT and IL-10/ mice were sensitized with SG for 5 , and the mice were then injected i.p. with
sheep anti-mouse GBM globulin at a dose of 30 mg per mouse. Total RNA was extracted from the kidneys of WT and IL-10/ mice with GN induced by aGBM or
control mice. Real-time PCR was performed for the analysis of IL-10 mRNA expression. Data are given as means  SD. B: Naive CD4þ T cells from WT and
IL-10/ mice were differentiated under nonpathogenic Th17, pathogenic Th17, or Th1 conditions for 3 days. Cells were then restimulated with PMA/ionomycin
for 5 hours; stained for intracellular IL-10, IL-17, IFN-g, IL-4, and Foxp3; and analyzed by ﬂow cytometry. Representative FACS dot plots gated on CD4þ cells and
the percentages of IL-17eproducing or IFN-geproducing or double-positive CD4þ cells are shown.
IL-10 Controls Pathogenic Th17 Cells(Figure 5C), with more cells in the spleens after induction of
GN (Figure 5C), suggesting that alterations of the immune
responses and immune microenvironment had occurred.
Meanwhile, signiﬁcantly higher Th17 immune responses
were observed in Rag1/ mice reconstituted with IL-10/
splenocytes (Figure 5D).The American Journal of Pathology - ajp.amjpathol.orgTo further clarify the results, CD4þ T cells were extracted
from spleens of WT and IL-10/ mice and then were
transferred into Rag1/ mice. After adoptive transfer of
CD4þ T cells into Rag1/mice, aGBM disease was induced
in these mice. Mice reconstituted with IL-10/CD4þ T cells
developed more severe renal disease compared with miceFigure 5 Transfer of IL-10/ spleen cells
induces more severe GN in Rag1/ mice. A: Spleen
cells from WT and IL-10/ mice were prepared and
were injected i.p. into Rag1/mice. Beginning the
next day, mice were sensitized with SG for 5 days,
and themicewere then injected i.p. with sheep anti-
mouse GBM globulin at a dose of 30 mg per mouse.
Renal injuries were assessed 20 days later. A: PAS
staining of glomeruli in mice reconstituted with
either WT or IL-10/ spleen cells. B: Quantiﬁcation
of histologic injury showed aggravation of GN in
mice reconstituted with either WT or IL-10/
spleen cells. gcs, glomerular cross section. *P <
0.05 versus mice transferred with IL-10/ spleen
cells. C: Spleens were enlarged and spleen cells were
signiﬁcantly increased in Rag1/ mice recon-
stituted with IL-10/ splenocytes. D: Splenocytes
were prepared from Rag1/ mice reconstituted
with either WT or IL-10/ spleen cells with GN
induced by aGBM globulin, and the cells were acti-
vated with SG for 24 hours. The supernatants were
harvested, and IL-17 protein levels were determined
by ELISA. Data are given as means  SD.
407
Figure 6 Transfer of IL-10/ CD4þ T cells induces more severe GN in Rag1/ mice. A: CD4þ cells from spleens of WT and IL-10/ mice were prepared
and injected i.p. into Rag1/ mice. From next day, mice were sensitized with SG for 5 days, and the mice were then injected i.p. with sheep anti-mouse GBM
globulin at a dose of 30 mg per mouse. Renal injuries were assessed 20 days later. A: PAS staining of glomeruli in mice reconstituted with either WT or IL-10/
CD4þ T cells. B: Quantiﬁcation of histologic injury showed aggravation of GN in mice reconstituted with either WT or IL-10/ CD4þ T cells (nZ 6 per group).
gcs, glomerular cross section. C: Functional injury indicated more albuminuria and higher serum urea levels in Rag1/ mice reconstituted with IL-10/ CD4þ
T cells (n Z 6 per group). Data are given as means  SD. *P < 0.05 versus IL-10/ mice.
Zhang et alreconstituted with WT CD4þ T cells (Figure 6A). IL-10/
CD4þ T cells transferred to Rag1/ mice developed severe
glomerular and interstitial injury (Figure 6B) and higher
albuminuria and serum urea (Figure 6C). Taken together,
these results demonstrate that the anti-inﬂammatory cytokine
IL-10 plays an important role in the control of GN devel-
opment, suggesting that IL-10 could be a therapeutic choice
for the treatment of immune-related GN.
IL-10 Regulates Pathogenic Th17 Cell Differentiation
in GN
To explore how IL-10 regulates pathogenic Th17 cell
development during GN, we focused on Rag1/ mice
reconstituted with WT and IL-10/ CD4þ T cells fol-
lowed by immunization with SG for 6 days. We found that
recipient mice reconstituted with IL-10/ CD4þ T cells
displayed enlarged spleens and increased splenocyte
counts (Figure 7A) compared with mice transferred with
WT CD4þ T cells. The spleen cells were restimulated with
SG for 24 hours, and IL-17eproducing CD4þ T cells were
analyzed by ﬂow cytometry. As expected, the percentage
of Th17 cells was signiﬁcantly higher in mice reconstituted
with IL-10/ CD4þ T cells (Figure 7B). In addition,
signiﬁcantly more inﬂammatory cells, including CD3þ
T cells, MAC-2 macrophages, and Gr-1þ neutrophils were
present in the kidneys of mice reconstituted with IL-10/
CD4þ T cells (Figure 7, C and D). These results demon-
strate that Rag1/ mice reconstituted with IL-10/ CD4þ
T cells develop more severe GN, with enhanced Th17
immune responses.408To further investigate the regulation of pathogenic Th17
cell differentiation by IL-10, we puriﬁed naive CD4þ T cells
from the spleens and lymph nodes of WT and IL-10/ mice
and stimulated the cells under nonpathogenic Th17 condi-
tions (TGF-b1 and IL-6), pathogenic Th17 conditions (TGF-
b1, IL-6, and IL-23), or Th1 conditions (IL-12) for 3 days.
The IL-17eproducing CD4þ T-cell population was signiﬁ-
cantly higher in IL-10/ cell cultures compared with WT
cell cultures (Figure 8A).18 Under pathogenic Th17 condi-
tions, the IL-17 and IFN-g double-positive cell populations
also signiﬁcantly increased, which is similar to the response
in IL-17 single-positive cells (Figure 8A). In addition, IFN-
geproducing cells were moderately increased (Figure 8A).
IL-17 production and mRNA expression of Th17 signature
molecules were also greatly enhanced in IL-10/mice under
pathogenic Th17 conditions (Figure 8, B and C). To conﬁrm
that IL-10 regulates the production of Th17 cells in vivo, we
prepared cells from the spleens and mesenteric lymph nodes
of WT and IL-10/mice with GN and then stimulated those
cells with PMA/ionomycin for 6 hours. Stimulated cells were
harvested, and the IL-17 and IFN-g double-positive CD4þ T
cells were analyzed by FACS. As expected, the percentage of
IL-17 and IFN-g double-positive CD4þ T cells was signiﬁ-
cantly higher in IL-10/mice than in WT mice (Figure 8D).
Taken together, these results suggest that IL-10 derived from
T cells regulates pathogenic Th17 cell development in GN.
Discussion
Although Th17 cells have been associated with the pathogen-
esis of inﬂammatory diseases, including GN, the regulation ofajp.amjpathol.org - The American Journal of Pathology
Figure 7 Th17 immune responses are enhanced in Rag1/ mice reconstituted with IL-10/ CD4þ T cells. CD4þ cells from spleens of WT and IL-10/
mice were prepared and injected i.p. into Rag1/ mice. Beginning the next day, mice were sensitized with SG for 5 days, and the mice were then injected i.p.
with sheep anti-mouse GBM globulin at a dose of 30 mg per mouse. The mice were sacriﬁced 20 days later. A: Spleens were enlarged and spleen cells were
signiﬁcantly increased in Rag1/ mice reconstituted with IL-10/ CD4þ T cells. B: Splenocytes were prepared from Rag1/ mice reconstituted with either
WT or IL-10/ spleen cells with GN induced by aGBM globulin, and the cells were activated with SG for 24 hours. The cells were harvested, and IL-17e
producing CD4þ T cells were analyzed by FACS. C: The inﬁltration of immune cells was analyzed by immunostaining in the kidneys. D: Quantiﬁcation of T cells,
macrophages, and neutrophils in the kidneys of mice reconstituted with either WT or IL-10/ CD4þ T cells. gcs, glomerular cross section. Data are given as
means  SD.
IL-10 Controls Pathogenic Th17 Cellspathogenic Th17 cell development during the process of
inﬂammatory diseases is incompletely understood.Therefore, it
is of great importance to identify the different factors that are
responsible for the suppression of pathogenic Th17 cell differ-
entiation in the target organs of inﬂammatory diseases. In the
present study, we demonstrated that IL-10edeﬁcient mice
exhibit exacerbation of GN after induction with aGBM glob-
ulin, with enhanced Th17 immune responses. We further
demonstrated that Rag1/ mice reconstituted with IL-10/
CD4þ T cells develop more severe GN with aGBM globulin
induction, which is associated with increased inﬁltration of
inﬂammatory cells into the kidneys. Finally, the IL-17 and
IFN-g double-positive cell populations were signiﬁcantly
greater in IL-10/ CD4þ T-cell cultures under pathogenicThe American Journal of Pathology - ajp.amjpathol.orgTh17 conditions compared with WT cell cultures, and double-
positive cells were also signiﬁcantly increased in IL-10/
mice with disease. These results suggest that IL-10 plays
a critical role in the control of pathogenic Th17 cell differenti-
ation during GN development.
IL-10 is critical in setting immune response magnitude.28
Its genetic ablation or inhibition leads to spontaneous colitis
and some other autoimmune and inﬂammatory diseases.
Previously, Kitching et al31 reported that endogenous IL-10
protects against crescentic GN by suppressing Th1 immune
responses. In addition, El-Shemi et al35 showed that IL-10
gene transfer suppressed experimental GN.35 However, the
exact actions performed by IL-10 in preventing the devel-
opment of GN are not well known. Recently, the new409
Figure 8 IL-10 suppresses pathogenic Th17 cell differentiation. A: Naive CD4þ T cells from WT and IL-10/ mice were differentiated under nonpathogenic
Th17, pathogenic Th17, or Th1 conditions for 3 days. Cells were then restimulated with PMA/ionomycin for 5 hours, stained for intracellular IL-17 and IFN-g,
and analyzed by ﬂow cytometry. Representative FACS dot plots gated on CD4þ cells and the percentages of IL-17eproducing or IFN-geproducing or double-
positive CD4þ cells are shown. B: IL-17 and IFN-g protein levels in the supernatants of cell culture under the pathogenic Th17 conditions prepared in A were
determined by ELISA. C: Total RNA was extracted from the pathogenic Th17 cells prepared in A, and real-time RT-qPCR was performed for the detection of
mRNA expression of cytokines. D: Cells from spleens and mesenteric lymph nodes were prepared from WT or IL-10/ mice with GN induced by aGBM, and the
cells were activated with PMA/ionomycin for 24 hours. IL-17 and IFN-g double-positive cells were analyzed by FACS. Data are given as means  SD. *P < 0.05,
**P < 0.01 versus IL-10/ Th17 cells.
Zhang et aldiagram indicates that Th17 cells instead of Th1 cells play
the critical role in the development of inﬂammatory
diseases. Therefore, the role of IL-10 in the development of
immune-related GN needs to be revisited. In the present
study, we demonstrated that IL-10edeﬁcient mice exhibit
worse GN in a mouse model induced with aGBM globulin,
with enhanced Th17 immune responses. These results
suggest that Th17 immune responses may be involved in the
exacerbation of GN in IL-10edeﬁcient mice.
IL-10 has been detected in human GN, in which IL-10
mRNA and protein are found in the more severe glomer-
ular lesions.36 IL-10 mRNA has been detected in the
kidneys of rats with accelerated anti-GBM GN.37 The
expression of IL-10 in a disease situation may reﬂect
initiation of protective mechanisms in the context of severe
glomerular injury; however, the molecular regulation of
IL-10 expression in a disease condition is still not fully
understood. IL-10 is produced by different cell types,410including macrophages, B cells, mesangial cells, kerati-
nocytes, and T cells.28 In the present study, we focused
on T-celleexpressed IL-10 in the pathogenesis of GN.
Rag1/ mice were reconstituted with either WT CD4þ
T cells or IL-10/ CD4þ T cells followed by induction
with anti-GBM GN. The results show that Rag1/ mice
reconstituted with IL-10/ developed more severe GN
and renal injuries compared with mice transferred with WT
cells. In addition, more Th17 cells were induced in mice
reconstituted with IL-10/ CD4þ T cells as well. These
results indicate that IL-10 produced by T cells negatively
regulates Th17 cell differentiation, resulting in the devel-
opment of GN. Although we found that different Th cells
produce IL-10 in vitro, it is still not clear which effector Th
cells are an important cellular source for IL-10 expression
in the development of GN.
Because Th1 and Th17 immune responses are signiﬁcantly
strengthened in IL-10/mice, it has been difﬁcult to resolveajp.amjpathol.org - The American Journal of Pathology
IL-10 Controls Pathogenic Th17 Cellsthe exact importance of which one (Th1 or Th17) is essential
for the immune-related diseases in IL-10/mice. Yen et al30
investigated IL-10 and IL-23p19 or IL-10 and IL-12p35
double knockout mice and found that IL-10 and IL-12p35
double-knockout mice develop colitis in a similar way as
IL-10 single-knockout mice. Although IL-10 and IL-23p19
double-knockout mice do not develop colitis,30 their results
strongly support the idea that Th17 but not Th1 immune
responses contribute to the pathogenesis of inﬂammatory
diseases in IL-10/ mice. In the present study, we observed
that IL-10/ or Rag1/ mice reconstituted with IL-10/
CD4þ T cells developed worse GN in terms of glomerular
crescent formation, serum urea nitrogen level, and inﬂam-
matory cell inﬁltration in the kidneys. Worsening of GN is
correlated with enhanced Th17 and Th1 cell development in
IL-10/ mice. Taken together, we believe that Th17 and
Th1cells regulated by IL-10 may contribute to the worsening
of GN in IL-10/mice. However, the relative importance of
Th17 and Th1 cells to the development of GN needs to be
further explored in future studies.
Although Th17 cells have been associated with the
induction of autoimmune/inﬂammatory diseases,
emerging data suggest that not all Th17 cells are patho-
genic and that exposure to IL-23 is crucial for their ability
to induce autoimmunity.11,14,38,39 To investigate the
regulation of nonpathogenic and pathogenic Th17 cell
development by IL-10, we puriﬁed naive CD4þ T cells
from WT and IL-10/ mice and activated the cells under
either nonpathogenic conditions or pathogenic conditions.
The IL-17-single-positive cells were signiﬁcantly
increased in IL-10/ cell culture under nonpathogenic or
pathogenic conditions compared with WT cell cultures.
However, IL-17/IFN-g double-positive cells were signif-
icantly increased in IL-10/ cell cultures under only
pathogenic Th17 conditions. In addition, the double-positive
cells were also signiﬁcantly increased in IL-10/ mice with
GN. These results imply that IL-10 preferentially regulates
pathogenic Th17 cell development. It is known that TGF-b1
is essential for nonpathogenic Th17 cell differentiation,
whereas autonomously produced TGF-b3 from Th17 cells is
critical in the induction of pathogenic Th17 cells.11 Although
the present study demonstrated that IL-10 is clearly involved
in the regulation of pathogenic Th17 cell induction, the
molecular mechanisms underlying this phenomenon are
incompletely understood. A future study will focus on the
regulation of key transcription factors, including RORgt,
IRF4, Ahr, and TGF-b3, by IL-10 under pathogenic Th17
conditions.
In summary, these studies clearly demonstrate that IL-10/
mice or Rag1/ mice reconstituted with IL-10/ CD4þ
T cells develop aggravated GN with enhanced Th17 and Th1
cell phenotypes. In addition, IL-10/ mice display enhanced
nonpathogenic and pathogenic Th17 cells.We suggest a novel
regulation of pathogenic Th17 cell development by IL-10.
These results support the concept that IL-10 expressed by
T cells may play an important role in the control ofThe American Journal of Pathology - ajp.amjpathol.orgpathogenesis of inﬂammatory diseases by controlling
nonpathogenic and pathogenic Th17 immune responses.References
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